Stem cell therapy provided to

• Kidney transplant patients for immunosuppression minimization
• Insulin-secreting cells (ISC) for treating Diabetes mellitus
• Neuronal stem cells for paraplegia and neuronal/ neuro-muscular disorders
• Cardiomyocytes for dilated cardiomyopathy
• Stem cell therapy for native kidney diseases
• Stem cell therapy for autoimmune diseases/ disorders
• Stem cell therapy for miscellaneous conditions not amenable to conventional therapy

CTRI Registration

• REF201702013341: Tolerance in Allogenic living-related renal transplantation: Comparison of pre-transplantation donor specific leucocyte infusion vs. stem cell transplantation (Public Title of Study)